Latest Breaking News On - Crinetics pharmaceuticals trading - Page 1 : comparemela.com

Brokerages Set Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) PT at $54 00

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]

Richard scott struthersRobertw bairdDana pizzutiCrinetics pharmaceuticalsHedge funds weigh in on crinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailySecurities exchange commissionCrinetics pharmaceuticals tradingCrinetics pharmaceuticals incEventide asset managementAnalyst recommendations for crinetics pharmaceuticalsVanguard group incJennison associatesGet free reportScott struthersExchange commission

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives Average Recommendation of Moderate Buy from Analysts

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives Average Recommendation of Moderate Buy from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Sees Large Increase in Short Interest

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandStephenf betzMarc wilsonNews ratings for crinetics pharmaceuticals dailyWellington management groupCrinetics pharmaceuticals company profileCrinetics pharmaceuticalsPricet rowe associates incCrinetics pharmaceuticals incJennison associatesVanguard group incSecurities exchange commissionInstitutional trading of crinetics pharmaceuticalsBlackrock incCrinetics pharmaceuticals trading

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $44 90 Average Price Target from Analysts

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $44 90 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenf betzRichard scott struthersJpmorgan chase coCrinetics pharmaceuticalsRoyal bankSecurities exchange commissionCrinetics pharmaceuticals incInsider transactions at crinetics pharmaceuticalsCantor fitzgeraldHighmark wealth managementNews ratings for crinetics pharmaceuticals dailyHedge funds weigh in on crinetics pharmaceuticalsOsaic holdings incChina universal asset management coJefferies financial groupCrinetics pharmaceuticals company profile

Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target Cut to $43 00 by Analysts at Robert W Baird

Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target Cut to $43 00 by Analysts at Robert W Baird
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Richard scott struthersRobertw bairdCoelho rogerio vivaldiPiper sandlerCharles schwab investment management incSecurities exchange commissionProfund advisorsCrinetics pharmaceuticalsAnalyst recommendations for crinetics pharmaceuticalsCrinetics pharmaceuticals incProshare advisorsInstitutional investors weigh in on crinetics pharmaceuticalsCrinetics pharmaceuticals company profileCrinetics pharmaceuticals tradingDimensional fund advisorsNews ratings for crinetics pharmaceuticals daily